🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests the effectiveness of golcadomide and rituximab as...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2025-04-02
Trial ID
NCT06834373
This phase Ib/II trial compares the effect of teclistamab and pomalidomide ...
Status
Recruiting
Location
ECOG-ACRIN Cancer Research Group
Start Date
2027-04-12
Trial ID
NCT07463807
Waldenström Macroglobulinemia (WM) is defined by a bone marrow lymphoplasma...
Status
Recruiting
Location
CHU Amiens
Start Date
2022-05-16
Trial ID
NCT04893564
Treatments Being Tested
The proposed study is a controlled laboratory study where stem cell content...
Status
Completed
Location
Auburn University
Start Date
2018-03-28
Trial ID
NCT03381599
Treatments Being Tested
This phase III trial compares standard chemotherapy to therapy with liposom...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2020-07-21
Trial ID
NCT04293562
Treatments Being Tested
Recent advances in understanding the molecular and cellular pathology of ma...
Status
Unknown
Location
DHR Health Institute for Research and Development
Start Date
2020-01-22
Trial ID
NCT05292430
Treatments Being Tested
This phase III trial studies iobenguane I-131 or lorlatinib and standard th...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2018-05-14
Trial ID
NCT03126916
Treatments Being Tested
This study will investigate the association between clonal hematopoiesis an...
Status
Recruiting
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2020-10-28
Trial ID
NCT06701214
Treatments Being Tested
This phase I trial studies the safety, side effects, best dose and effectiv...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2024-04-09
Trial ID
NCT06048250
RATIONALE: Aflibercept may stop the growth of cancer cells by blocking bloo...
Status
Withdrawn
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT00601991
Treatments Being Tested